Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 17 | 2013 | 328 | 1.580 |
Why?
|
| Tissue and Organ Procurement | 2 | 2022 | 164 | 0.550 |
Why?
|
| Tissue Donors | 5 | 2022 | 195 | 0.490 |
Why?
|
| Hospitals, University | 2 | 2011 | 169 | 0.440 |
Why?
|
| Heart Diseases | 3 | 2011 | 276 | 0.420 |
Why?
|
| Aortic Valve | 6 | 2010 | 249 | 0.360 |
Why?
|
| Mitral Valve | 4 | 2010 | 166 | 0.330 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2004 | 250 | 0.310 |
Why?
|
| Heart Valve Prosthesis | 5 | 2010 | 222 | 0.280 |
Why?
|
| Transplantation | 1 | 2006 | 23 | 0.270 |
Why?
|
| Embolectomy | 1 | 2004 | 5 | 0.250 |
Why?
|
| Coronary Artery Bypass | 3 | 2011 | 218 | 0.220 |
Why?
|
| Pulmonary Artery | 1 | 2004 | 323 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 253 | 0.200 |
Why?
|
| Thyroxine | 1 | 2022 | 62 | 0.200 |
Why?
|
| Bioprosthesis | 3 | 2010 | 101 | 0.190 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2010 | 164 | 0.190 |
Why?
|
| Middle Aged | 25 | 2011 | 21147 | 0.170 |
Why?
|
| South Carolina | 7 | 2011 | 2752 | 0.160 |
Why?
|
| Humans | 41 | 2022 | 68618 | 0.150 |
Why?
|
| Male | 27 | 2013 | 37321 | 0.150 |
Why?
|
| Myocardium | 5 | 2007 | 1204 | 0.150 |
Why?
|
| Mammary Arteries | 2 | 2004 | 18 | 0.140 |
Why?
|
| Female | 23 | 2013 | 38074 | 0.130 |
Why?
|
| Ventricular Septal Rupture | 1 | 1995 | 2 | 0.130 |
Why?
|
| Survival Rate | 3 | 2011 | 1056 | 0.130 |
Why?
|
| Child | 6 | 2011 | 6405 | 0.120 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1994 | 25 | 0.120 |
Why?
|
| Adult | 18 | 2022 | 21403 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2011 | 7277 | 0.120 |
Why?
|
| Time Factors | 8 | 2011 | 4655 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2007 | 106 | 0.110 |
Why?
|
| Patient Selection | 3 | 2006 | 592 | 0.110 |
Why?
|
| Survival Analysis | 4 | 2010 | 714 | 0.100 |
Why?
|
| Vasoconstriction | 2 | 2004 | 81 | 0.100 |
Why?
|
| Hospital Mortality | 2 | 2011 | 384 | 0.100 |
Why?
|
| Heart Valve Diseases | 3 | 2010 | 123 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2006 | 450 | 0.100 |
Why?
|
| Aged | 11 | 2011 | 14862 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2011 | 3259 | 0.100 |
Why?
|
| Adolescent | 5 | 2011 | 8912 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1991 | 47 | 0.090 |
Why?
|
| Hemodynamics | 3 | 2022 | 705 | 0.090 |
Why?
|
| Myocardial Revascularization | 2 | 1988 | 56 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 2011 | 110 | 0.090 |
Why?
|
| Postoperative Complications | 7 | 2010 | 1615 | 0.090 |
Why?
|
| Organ Transplantation | 1 | 1991 | 110 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 163 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 1991 | 177 | 0.080 |
Why?
|
| Thoracic Arteries | 1 | 1988 | 10 | 0.080 |
Why?
|
| Factor VIIa | 1 | 2008 | 25 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 69 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2011 | 7029 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2011 | 2455 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2007 | 44 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2008 | 113 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 742 | 0.070 |
Why?
|
| Infant | 2 | 2011 | 2891 | 0.070 |
Why?
|
| Methylprednisolone | 2 | 2022 | 99 | 0.070 |
Why?
|
| Comprehensive Health Care | 1 | 2006 | 26 | 0.070 |
Why?
|
| Renal Replacement Therapy | 1 | 2006 | 40 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2007 | 140 | 0.070 |
Why?
|
| Myocardial Contraction | 3 | 1985 | 383 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2006 | 85 | 0.060 |
Why?
|
| CD3 Complex | 1 | 2004 | 35 | 0.060 |
Why?
|
| Papaverine | 1 | 2004 | 10 | 0.060 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2004 | 12 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 696 | 0.060 |
Why?
|
| Antilymphocyte Serum | 1 | 2004 | 52 | 0.060 |
Why?
|
| Natriuretic Agents | 1 | 2004 | 9 | 0.060 |
Why?
|
| Program Development | 1 | 2006 | 240 | 0.060 |
Why?
|
| Lung Transplantation | 2 | 1996 | 88 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2011 | 3187 | 0.060 |
Why?
|
| Emergencies | 1 | 2004 | 107 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 223 | 0.060 |
Why?
|
| Disease Management | 1 | 2006 | 248 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2004 | 101 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2004 | 122 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 212 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 129 | 0.060 |
Why?
|
| Heparin | 1 | 2004 | 205 | 0.060 |
Why?
|
| Opportunistic Infections | 2 | 1994 | 33 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 138 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 134 | 0.060 |
Why?
|
| Heart Failure | 4 | 2006 | 1180 | 0.060 |
Why?
|
| Fibroma | 1 | 2003 | 20 | 0.050 |
Why?
|
| Young Adult | 2 | 2011 | 5717 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 249 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 33 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 365 | 0.050 |
Why?
|
| Ventricular Function | 1 | 1983 | 93 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2007 | 902 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 483 | 0.050 |
Why?
|
| Brain Death | 1 | 2022 | 34 | 0.050 |
Why?
|
| Graft Rejection | 3 | 1998 | 458 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2004 | 356 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 107 | 0.050 |
Why?
|
| Coronary Circulation | 2 | 2000 | 136 | 0.050 |
Why?
|
| Endothelins | 1 | 2000 | 57 | 0.040 |
Why?
|
| Nifedipine | 1 | 2000 | 40 | 0.040 |
Why?
|
| Diltiazem | 1 | 2000 | 26 | 0.040 |
Why?
|
| Amlodipine | 1 | 2000 | 31 | 0.040 |
Why?
|
| Reoperation | 3 | 2008 | 467 | 0.040 |
Why?
|
| Radial Artery | 1 | 2000 | 43 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 138 | 0.040 |
Why?
|
| Kidney | 1 | 2004 | 945 | 0.040 |
Why?
|
| Biopsy | 2 | 2007 | 540 | 0.040 |
Why?
|
| Gelatinases | 1 | 1998 | 12 | 0.040 |
Why?
|
| Collagenases | 1 | 1998 | 34 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 67 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2011 | 880 | 0.040 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1998 | 22 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2010 | 2358 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 137 | 0.040 |
Why?
|
| Heart Ventricles | 5 | 2006 | 738 | 0.040 |
Why?
|
| Prosthesis Design | 3 | 2010 | 301 | 0.040 |
Why?
|
| Risk Factors | 4 | 2011 | 5731 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2010 | 4848 | 0.030 |
Why?
|
| Thoracostomy | 1 | 1996 | 6 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2007 | 481 | 0.030 |
Why?
|
| Esophageal Diseases | 1 | 1996 | 95 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2004 | 317 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1995 | 164 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1995 | 216 | 0.030 |
Why?
|
| Prosthesis Failure | 2 | 2010 | 130 | 0.030 |
Why?
|
| Mycobacterium scrofulaceum | 1 | 1994 | 1 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1994 | 20 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 1994 | 87 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1994 | 75 | 0.030 |
Why?
|
| Endocardium | 1 | 1994 | 101 | 0.030 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 1994 | 37 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1994 | 61 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 2007 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1851 | 0.030 |
Why?
|
| Acute Kidney Injury | 2 | 2008 | 232 | 0.030 |
Why?
|
| Exophiala | 1 | 1992 | 4 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2007 | 145 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 1994 | 167 | 0.030 |
Why?
|
| Alprostadil | 1 | 1992 | 20 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2008 | 344 | 0.030 |
Why?
|
| Amiodarone | 1 | 1992 | 21 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 297 | 0.030 |
Why?
|
| Actuarial Analysis | 2 | 2003 | 23 | 0.030 |
Why?
|
| Mycoses | 1 | 1992 | 60 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 2176 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1992 | 121 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 1991 | 9 | 0.020 |
Why?
|
| Debridement | 1 | 1991 | 55 | 0.020 |
Why?
|
| Pulmonary Valve | 1 | 1991 | 40 | 0.020 |
Why?
|
| Propensity Score | 1 | 2011 | 117 | 0.020 |
Why?
|
| Cardiac Output | 3 | 2004 | 133 | 0.020 |
Why?
|
| Prostaglandin Endoperoxides | 1 | 1990 | 13 | 0.020 |
Why?
|
| Prostaglandins H | 1 | 1990 | 32 | 0.020 |
Why?
|
| Thromboxane A2 | 1 | 1990 | 88 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 242 | 0.020 |
Why?
|
| Receptors, Prostaglandin | 1 | 1990 | 74 | 0.020 |
Why?
|
| Lung | 1 | 1994 | 849 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 245 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2006 | 275 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1992 | 232 | 0.020 |
Why?
|
| Kinetics | 2 | 2007 | 1047 | 0.020 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 31 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1988 | 168 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 792 | 0.020 |
Why?
|
| Polyribosomes | 1 | 2007 | 24 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2007 | 42 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 71 | 0.020 |
Why?
|
| Pneumonia | 1 | 2008 | 110 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2004 | 951 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Thrombosis | 1 | 2008 | 218 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 181 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 337 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2004 | 514 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2006 | 119 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2007 | 525 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2673 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 807 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 349 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 562 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1986 | 213 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 392 | 0.020 |
Why?
|
| Hirudins | 1 | 2004 | 32 | 0.020 |
Why?
|
| Heart Atria | 1 | 2006 | 206 | 0.020 |
Why?
|
| Spasm | 1 | 2004 | 18 | 0.020 |
Why?
|
| Diuresis | 1 | 2004 | 20 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 626 | 0.020 |
Why?
|
| Injections | 1 | 2004 | 119 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 49 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1984 | 122 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2004 | 107 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 193 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 230 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2004 | 179 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2004 | 102 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 622 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1664 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1985 | 358 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 318 | 0.010 |
Why?
|
| Collagen | 1 | 2006 | 636 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 3705 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 1619 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1983 | 238 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 2093 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1992 | 165 | 0.010 |
Why?
|
| Palliative Care | 1 | 2003 | 271 | 0.010 |
Why?
|
| Dogs | 3 | 1986 | 490 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 515 | 0.010 |
Why?
|
| Biomarkers | 1 | 2004 | 1593 | 0.010 |
Why?
|
| Cause of Death | 1 | 1999 | 241 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1998 | 20 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1998 | 59 | 0.010 |
Why?
|
| Stroke | 1 | 2011 | 2163 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 1998 | 74 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1998 | 254 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1998 | 160 | 0.010 |
Why?
|
| Hypertension | 1 | 1986 | 1535 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1996 | 12 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1998 | 682 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1995 | 87 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1994 | 20 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1994 | 24 | 0.010 |
Why?
|
| Schools, Medical | 1 | 1995 | 157 | 0.010 |
Why?
|
| Flucytosine | 1 | 1992 | 5 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1992 | 26 | 0.010 |
Why?
|
| Walking | 1 | 1995 | 241 | 0.010 |
Why?
|
| Tachycardia | 1 | 1992 | 53 | 0.010 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1992 | 73 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1992 | 289 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 567 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1992 | 161 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1992 | 649 | 0.010 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 1990 | 48 | 0.010 |
Why?
|
| Receptors, Thromboxane | 1 | 1990 | 122 | 0.010 |
Why?
|
| Ligands | 1 | 1990 | 317 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1985 | 1451 | 0.000 |
Why?
|
| Elasticity | 1 | 1986 | 103 | 0.000 |
Why?
|
| Pulmonary Circulation | 1 | 1986 | 79 | 0.000 |
Why?
|
| Diastole | 1 | 1986 | 161 | 0.000 |
Why?
|
| Calcium | 1 | 1990 | 929 | 0.000 |
Why?
|
| Transducers, Pressure | 1 | 1985 | 14 | 0.000 |
Why?
|
| Venae Cavae | 1 | 1985 | 16 | 0.000 |
Why?
|
| Consciousness | 1 | 1985 | 17 | 0.000 |
Why?
|
| Constriction | 1 | 1985 | 37 | 0.000 |
Why?
|
| Rheology | 1 | 1985 | 25 | 0.000 |
Why?
|
| Microspheres | 1 | 1985 | 59 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 2324 | 0.000 |
Why?
|
| Methods | 1 | 1984 | 156 | 0.000 |
Why?
|
| Stress, Mechanical | 1 | 1985 | 208 | 0.000 |
Why?
|
| Organ Preservation | 1 | 1984 | 69 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1984 | 90 | 0.000 |
Why?
|
| Animals | 3 | 1986 | 20881 | 0.000 |
Why?
|
| Biomechanical Phenomena | 1 | 1984 | 368 | 0.000 |
Why?
|
| Heart Rate | 1 | 1985 | 568 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1985 | 313 | 0.000 |
Why?
|
| Heart | 1 | 1984 | 850 | 0.000 |
Why?
|